Pfizer Inc. shares ticked up modestly Tuesday as investors weighed fresh positive oncology data against the pharmaceutical ...

Executives from Varex Imaging (NASDAQ:VREX) said recent geopolitical events and tariff volatility have not materially changed demand trends for the company so far in 2026, while outlining expectations ...

Yet compliance alone does not differentiate suppliers — what separates reliable vendors from cost-cutting alternatives is the ...

Executives from Varex Imaging (NASDAQ:VREX) outlined the company’s business mix, demand trends, tariff actions, and several growth initiatives during a fireside chat featuring CFO Sam Maheshwari and ...

Walk through many affluent neighborhoods today and you can see the signs of a new kind of pet culture. Dogs ride in strollers ...

In undertaking this survey, researchers aimed to assess the limitations of ctDNA testing in the clinic, as well as areas in which it is considered clinically meaningful.

Learn how ctDNA/MRD testing guides gastroesophageal cancer care—patient counseling, coverage hurdles, and what rising ctDNA ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

Novel agent outperforms placebo in phase II trial, but is it enough?

CHENGDU, China and JANESVILLE, Wis., March 26, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu, China), a global radiopharmaceutical CRDMO, today announced the execution of a Master Radioisotope ...

A new high-energy CT system allows detailed inspection of large objects, enabling non-destructive testing of complex components while maintaining their original orientation and structure.